Gastric Pathophysiology in Diabetes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorInstitute for Clinical and Experimental Medicine

About this trial

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated.

For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

Eligibility criteria

Qualifiers

Diabetes mellitus type I or II, minimal duration of the disease 3 years, minimal duration of specific treatment (drugs, insulin) 2 years

Disqualifiers

Diabetes mellitus type II being treated with a diet only

Severe acute decompensation of diabetes (uncontrolled diabetes) necessitating hospitalization

Concomitant treatment with more than one prokinetic agent

Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

120 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Institute for Clinical and Experimental Medicine

Lead sponsor

Poliklinika Agel, Dopravni zdravotnictvi a.s.

Collaborator